Regenxbio Inc
NASDAQ:RGNX
Market Cap (Intraday) | 1.95B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $47.99 |
50-Day MA | $41.01 |
200-Day MA | $35.69 |
REGENXBIO Inc. Stock, NASDAQ:RGNX
9600 BLACKWELL ROAD, SUITE 210, ROCKVILLE, MD 20850
United States of America
Phone: 240-552-8181
Number of Employees: 192
Description
Developing gene therapies for rare diseases with a proprietary delivery platform.